The tirzepatide 30mg pen: what it contains and how each injection works

Step 1 — Understanding which pen you actually have (and why 30mg does not exist)

The confusion around a "tirzepatide 30mg pen" usually comes from one of two places: a misread of pen labelling, or an encounter with an unlicensed product online. The licensed UK strengths for Mounjaro are 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg per weekly injection. Each KwikPen holds four of those weekly doses, so a 10mg pen contains 40mg of tirzepatide in total across its four cartridge chambers, but the dose delivered in a single injection remains 10mg. No configuration of the licensed pen adds up to 30mg per injection. If you have seen a product described as a tirzepatide 30mg pen, that labelling does not correspond to anything in the MHRA-authorised range.

The MHRA has warned repeatedly about counterfeit weight-loss pens sold online, including products with unfamiliar labelling that do not match the genuine supply chain. Reporting suspect products through the Yellow Card scheme helps the regulator act quickly. Always verify that any pharmacy supplying you is registered on the GPhC register before handing over payment or personal details.

If you want to understand the full range of genuine pens and what each strength is prescribed for, the tirzepatide pen guide on this site covers each option in detail.

Step 2, Preparing the pen correctly before each injection

Assuming you hold a genuine Mounjaro KwikPen at the right strength, preparation follows a consistent sequence. The pen lives in the fridge (ideally towards the front of the fridge door so it is easy to reach) stored between 2°C and 8°C. Before injecting, it should be brought to room temperature; the exact time window is specified in your Patient Information Leaflet, and that document is the reference to follow, not general internet guidance.

A fresh needle is attached for every single injection. Reusing needles blunts the tip and increases injection-site discomfort and infection risk. Replacement pen needles should always be to hand so this step is never skipped. After attaching the needle, check the liquid through the pen window: it should be clear and colourless to slightly yellow, with no particles. If it looks cloudy, discoloured or contains visible particles, do not use it, contact your prescriber.

Clean the chosen injection site with an alcohol swab and allow it to dry fully before inserting the needle. Injecting through wet skin stings more and can affect absorption slightly.

Step 3, Choosing an injection site and completing the injection safely

The three licensed injection sites are the abdomen, the front of the thigh and the outer upper arm. Rotating between sites with each weekly injection reduces the chance of localised skin changes, lipohypertrophy, a thickening under the skin that can affect medicine absorption, is a real risk if you always inject in exactly the same spot. Keep a loose mental note of where you injected last week.

Press the pen firmly against the skin, unlock the cap if prompted by your pen's design, then press and hold the injection button until you hear or feel the pen confirm the dose is complete. The NHS patient-level guidance on tirzepatide on NHS.uk covers the injection technique and when to seek advice if something feels wrong. After the injection, activate the needle shield, remove the needle and place it immediately into a suitable sharps container. Never recap used needles.

Used needles are clinical waste. A proper sharps bin is the correct disposal method; your local council or GP surgery can advise on collection. Standard household bins are not appropriate.

Step 4, What happens if you are on the wrong dose or have questions after injecting

The prescriber who reviewed your consultation decides which strength of pen you receive and when to move up. That decision is based on your response and tolerability, not a fixed calendar. The most common side effects are gastrointestinal (nausea, loose stools, burping, indigestion) and they tend to be most noticeable in the first week or two after starting or increasing the dose, then settle for most people. If they do not settle, or if you experience severe stomach pain that spreads toward your back, contact a clinician promptly rather than waiting for your next scheduled check-in.

If a dose increase takes you to a pen strength you have not used before, the 60mg pen and 90mg pen pages explain what those higher-capacity pens contain and what to expect. For a broader picture of how Mounjaro works as a treatment, including its clinical trial results and eligibility criteria, that page brings together everything in one place. If cost is on your mind as you think through your options, the Mounjaro pricing guide sets out what private treatment typically involves.

Treatment is a Prescription-Only Medicine. If you have not yet had a clinical assessment and want to understand whether tirzepatide is appropriate for you, starting a free consultation is the first step, a GPhC-registered prescriber, not automated software, reads your answers and makes the clinical call.